In Vivo Labeling of Brain Capillary Endothelial Cells after Intravenous Injection of Monoclonal Antibodies Targeting the Transferrin Receptor
暂无分享,去创建一个
[1] R. Gabathuler,et al. Approaches to transport therapeutic drugs across the blood–brain barrier to treat brain diseases , 2010, Neurobiology of Disease.
[2] S. Cazaubon,et al. The blood-brain barrier in brain homeostasis and neurological diseases. , 2009, Biochimica et biophysica acta.
[3] R. Deane,et al. Clearance of amyloid-β peptide across the blood-brain barrier: Implication for therapies in Alzheimer’s disease , 2009 .
[4] J. Scherrmann,et al. CNS Delivery Via Adsorptive Transcytosis , 2008, The AAPS Journal.
[5] W. Jefferies,et al. A Unique Carrier for Delivery of Therapeutic Compounds beyond the Blood-Brain Barrier , 2008, PloS one.
[6] Michel Demeule,et al. Identification and Design of Peptides as a New Drug Delivery System for the Brain , 2008, Journal of Pharmacology and Experimental Therapeutics.
[7] B. Zlokovic. The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders , 2008, Neuron.
[8] E. Morgan,et al. Iron trafficking inside the brain , 2007, Journal of neurochemistry.
[9] B. Davidson,et al. Transvascular delivery of small interfering RNA to the central nervous system , 2007, Nature.
[10] W. Pardridge. Drug Targeting to the Brain , 2007, Pharmaceutical Research.
[11] A. Fagan,et al. P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. , 2005, The Journal of clinical investigation.
[12] G. Storm,et al. Targeting Anti—Transferrin Receptor Antibody (OX26) and OX26-Conjugated Liposomes to Brain Capillary Endothelial Cells Using In Situ Perfusion , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[13] G. Bu,et al. Efficient transfer of receptor-associated protein (RAP) across the blood-brain barrier , 2004, Journal of Cell Science.
[14] Sylvain V Costes,et al. Automatic and quantitative measurement of protein-protein colocalization in live cells. , 2004, Biophysical journal.
[15] T. Shimazoe,et al. In vivo delivery of glial cell-derived neurotrophic factor across the blood-brain barrier by gene transfer into brain capillary endothelial cells. , 2003, Human gene therapy.
[16] Hongzhe Sun,et al. Targeted Drug Delivery via the Transferrin Receptor-Mediated Endocytosis Pathway , 2002, Pharmacological Reviews.
[17] Michel Demeule,et al. High transcytosis of melanotransferrin (P97) across the blood–brain barrier , 2002, Journal of neurochemistry.
[18] Y. Kaneda,et al. Transluminal Gene Transfer into Brain Capillary Endothelial Cells In Vivo with HVJ-liposomes , 2002, Journal of drug targeting.
[19] E. Morgan,et al. Restricted transport of anti‐transferrin receptor antibody (OX26) through the blood–brain barrier in the rat , 2001, Journal of neurochemistry.
[20] M. J. Coloma,et al. Transport Across the Primate Blood-Brain Barrier of a Genetically Engineered Chimeric Monoclonal Antibody to the Human Insulin Receptor , 2000, Pharmaceutical Research.
[21] B. Engelhardt,et al. Targeting rat anti-mouse transferrin receptor monoclonal antibodies through blood-brain barrier in mouse. , 2000, The Journal of pharmacology and experimental therapeutics.
[22] B. Engelhardt,et al. Immunohistochemical localization of the murine transferrin receptor (TfR) on blood–tissue barriers using a novel anti-TfR monoclonal antibody , 1998, Histochemistry and Cell Biology.
[23] T. Moos. Immunohistochemical localization of intraneuronal transferrin receptor immunoreactivity in the adult mouse central nervous system , 1996, The Journal of comparative neurology.
[24] R. Broadwell,et al. Transcytosis of Protein through the Mammalian Cerebral Epithelium and Endothelium III. Receptor-Mediated Transcytosis through the Blood–Brain Barrier of Blood-Borne Transferrin and Antibody against the Transferrin Receptor , 1996, Experimental Neurology.
[25] W. Pardridge,et al. Transport of [125I]transferrin through the rat blood-brain barrier , 1995, Brain Research.
[26] T. Moos. Age-dependent uptake and retrograde axonal transport of exogenous albumin and transferrin in rat motor neurons , 1995, Brain Research.
[27] U. Bickel,et al. In vivo demonstration of subcellular localization of anti-transferrin receptor monoclonal antibody-colloidal gold conjugate in brain capillary endothelium. , 1994, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[28] W. Pardridge,et al. Transport of Human Recombinant Brain-Derived Neurotrophic Factor (BDNF) Through the Rat Blood−Brain Barrier in Vivo Using Vector-Mediated Peptide Drug Delivery , 1994, Pharmaceutical Research.
[29] W. Pardridge,et al. Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo. , 1991, The Journal of pharmacology and experimental therapeutics.
[30] R. Starzyk,et al. Anti-transferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[31] D. Mash,et al. Characterization and Distribution of Transferrin Receptors in the Rat Brain , 1990, Journal of neurochemistry.
[32] B. Giometto,et al. Transferrin receptors in rat central nervous system An immunocytochemical study , 1990, Journal of the Neurological Sciences.
[33] W. Pardridge,et al. Human blood-brain barrier transferrin receptor. , 1987, Metabolism: clinical and experimental.
[34] W. Jefferies,et al. Transferrin receptor on endothelium of brain capillaries , 1984, Nature.
[35] P. Dore‐Duffy,et al. Morphology and properties of pericytes. , 2011, Methods in molecular biology.
[36] R. Deane,et al. Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease. , 2009, CNS & neurological disorders drug targets.
[37] T. Nishizaki,et al. Transferrin receptors in injured brain , 2004, Acta Neuropathologica.
[38] W. Pardridge,et al. Global non-viral gene transfer to the primate brain following intravenous administration. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.
[39] F. Calon,et al. Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism. , 2003, Human gene therapy.
[40] W. Pardridge,et al. Noninvasive gene targeting to the brain. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[41] B. Bregman,et al. Localization of transferrin within the developing vertebrate nervous system. , 1988, Revue neurologique (Paris).